The treatment of Juvenile Idiopathic Arthritis (JI aims to reduce inflammation, relieve symptoms, and prevent long-term joint damage. The approach is multidisciplinary and often involves pediatric rheumatologists, physiotherapists, and ophthalmologists. Treatment modalities include:
1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs):
- Indications: First-line treatment for pain and inflammation.
- Common Medications: Ibuprofen, naproxen.
- Mechanism: NSAIDs work by reducing prostaglandin synthesis and have anti-inflammatory, analgesic, and antipyretic effects.
- Side Effects: Gastrointestinal upset, renal issues, and increased risk of cardiovascular events with long-term use.
2. Disease-modifying Antirheumatic Drugs (DMARDs):
- Methotrexate: The mainstay of treatment for most JIA subtypes. It reduces inflammation and prevents joint damage by modulating the immune system.
- Sulfasalazine and leflunomide: Alternatives in some cases.
- Side Effects: Hepatotoxicity, gastrointestinal distress, and blood dyscrasias.
3. Biologic Agents:
- Tumor Necrosis Factor (TNF)-inhibitors (e.g., etanercept, adalimuma: Used when disease is resistant to conventional DMARDs.
- Interleukin-6 (IL-6) inhibitors (e.g., tocilizuma: Used in systemic JIA or when other biologics are ineffective.
- Indications: Reserved for moderate to severe disease that is unresponsive to DMARDs.
- Side Effects: Risk of infections, malignancies, and immune reactions.
4. Corticosteroids:
- Indications: Used in severe, active disease or during flare-ups to rapidly control inflammation.
- Routes of Administration: Oral, intra-articular, or intravenous depending on disease severity.
- Side Effects: Long-term use can cause growth retardation, osteoporosis, and cataracts.
5. Physical and Occupational Therapy:
- A critical component of treatment to maintain joint mobility, muscle strength, and overall functionality. Regular physiotherapy helps prevent deformities and enhances quality of life.
6. Surgical Treatment:
- In severe cases with significant joint damage or deformities, surgical interventions such as synovectomy or joint replacement may be required.
Step 2: Management of Complications.
- Uveitis: Regular ophthalmologic monitoring is essential. Treatment may include topical corticosteroids or systemic immunosuppressive therapy if uveitis develops.
- Growth and Development Issues: Long-term monitoring is needed to manage growth issues due to disease activity or medication side effects.